cns.jpg (2811 bytes)



Journal Home
Editorial Board
Instructions for Contributors
Subscription Rates

© Neva Press, Inc. 2005

CNS Drug Reviews

Table of Contents

Volume 11, No. 3


229 Cotinine, a Neuroactive Metabolite of Nicotine:  Potential for Treating Disorders of Impaired Cognition
Alvin V. Terry, Jr., Caterina M. Hernandez, Elizabeth J. Hohnadel, Kristy P. Bouchard, and Jerry J. Buccafusco
[Abstract] [Article] [Single Reprint]
253 Ropinirole, a Non-Ergoline Dopamine Agonist
Wolfgang H. Jost and Dieter Angersbach
[Abstract] [Article] [Single Reprint]
273 Pharmacological Properties, Central Nervous System Effects, and Potential Therapeutic Applications of Atipamezole, a Selective α2-Adrenoceptor Antagonist
Antti Pertovaara, Antti Haapalinna, Jouni Sirviö and Raimo Virtanen
[Abstract] [Article] [Single Reprint]
289   Preclinical Neuropharmacology of Naratriptan
Geoffrey A. Lambert
[Abstract] [Article] [Single Reprint]
317   Clinical Potential of GABAB Receptor Modulators
Jennifer Ong and David I. B. Kerr
[Abstract] [Article] [Single Reprint]
335   Alzheimer’s Association International Conference on Prevention of Dementia.  Washington, D.C.  June 18–21, 2005.
Alexander Scriabine
[Article] [Single Reprint]
339   IBC’s 10th Annual World Congress.  Drug Discovery Technology and Development 2005.  Boston, MA.  August 8–11, 2005.
Alexander Scriabine
[Article] [Single Reprint]